All Biotech News

List of articles in category All Biotech News
Title	Published Date
Morphochem’s Investigational New Drug (IND) Application Accepted by the FDA – Novel Antibacterial for Intravenous Treatment of Clostridium difficile Infections (CDI), MCB3837/MCB3681, Can Now Move into Phase 2	06/22/2016
RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors	06/22/2016
RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D	06/21/2016
Polyganics Announces CE Mark for NEUROCAP®, the Nerve Capping Device for Treatment and Prevention of Symptomatic Neuroma	06/21/2016
TVM Life Science Ventures VII Announces Investment in Mediti Pharma Inc. for the Development of a Novel Treatment for Alzheimer's Disease Psychosis	06/20/2016
Molecular Breast Cancer Subtyping: Study Confirms Advantages of the In Vitro Diagnostic Test Kit Mammatyper® over Immunohistochemistry (IHC)	06/16/2016
Jörn Aldag Appointed CEO of Hookipa Biotech	06/16/2016
TROD Medical’s Prostate Focal Therapy Device Encage™ Advances in US and UK Clinical Studies	06/16/2016
Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System	06/15/2016
Biotage Achieves ISO 14001:2004 Certification	06/14/2016
New Sartorius Stedim BioOutsource Microsite Goes Live	06/14/2016
Sartorius Stedim Biotech Presents Virosart® Media	06/13/2016
New Data Shows Agendia’s MammaPrint® can Prevent Under and Over Treatment of Breast Cancer Patients with an Intermediate/Indeterminate OncotypeDx Recurrence Score	06/07/2016
New On-line SPE Cartridges from Biotage	06/07/2016
Fujifilm Diosynth Announces Collaboration on a New 20,000-Liter Microbial Biologics Facility for Use by Its Contract Development and Manufacturing Customers	06/06/2016
Ganymed's IMAB362 Extends Survival in Gastric Cancer	06/05/2016
BioGenes and Eurofins BioPharma Product Testing Munich to Cooperate in the Area of HCP Analysis	06/03/2016
Emperra Partners with the Federal Initiative "German Accelerator Life Sciences" to Expand to US	06/03/2016
Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to their Medical Advisory Board	06/01/2016
Merus N.V. Signs Commercial Multi-Product License for ProBioGen’s GlymaxX® ADCC Enhancement Technology	06/01/2016
ChemConnection and Cristal Therapeutics Announce Successful GMP Production of CriPec® Docetaxel for Phase 1/2a Clinical Trials	06/01/2016
Clinical Study in UK to Evaluate ReGenerCell™ for Diabetic Foot Ulcer Treatment	05/31/2016
Evercyte and VTU Technology Collaborate On Development of Recombinant Media Supplements	05/24/2016
ProBioGen Will License GlymaxX® to Thermo Fisher Scientific for Use in Developing Allergy Diagnostics	05/18/2016
Ganymed to Present Exciting Phase II Clinical Data for IMAB362 in Gastroesophageal Cancer at ASCO 2016 Annual Meeting	05/17/2016
Vetter is a Winner of the AbbVie TRIUMPH AWARD	05/11/2016
LDC and Boehringer Ingelheim Join Forces to Discover a Novel Approach for the Treatment of Schizophrenia	05/11/2016
EMA/CHMP Adopts Positive Opinion for ITM´s EndolucinBeta®	05/10/2016
RedHill Biopharma Announces National Cancer Institute Grant Supporting YELIVA™ Phase II Hepatocellular Carcinoma Study	05/05/2016
Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference	05/04/2016

Page 43 of 84